Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...